Scott Platshon

Partner at EcoR1 Capital

Mr. Platshon joined EcoR1 Capital, LLC in October 2015 after spending a year at Aquilo Partners, a boutique life sciences investment bank. Alongside Ms. Stout, Mr. Platshon serves as an analyst and is responsible for due diligence and analysis of biotechnology companies for value-oriented investment opportunities. At Aquilo, Mr. Platshon prepared valuation materials and performed due diligence on M&A, licensing, and private placement transactions in the biotech, pharmaceutical and tools & diagnostics sector. Mr. Platshon holds a Bachelor of Science in Bioengineering from Stanford University, and was advised by Karl Deisseroth, the inventor of optogenetics and CLARITY, two breakthrough neuroscience technologies.

Links

Previous companies

Ashvattha Therapeutics logo
PellePharm logo
Janux Therapeutics logo

Timeline

  • Partner

    Current role